Phage display is a groundbreaking technique that has revolutionized the way we study molecular interactions and develop targeted therapeutics. Since its introduction in the 1980s, this technology has become a cornerstone in the fields of antibody engineering, drug discovery, and biomarker identification.
What Is Phage Display?
Phage display is a molecular biology method in which a library of peptides, proteins, or antibody fragments is genetically fused to the coat proteins of bacteriophages—viruses that infect bacteria. These foreign sequences are displayed on the surface of the phage, while the genetic information encoding them resides within. This physical linkage between phenotype and genotype enables rapid identification of high-affinity binders to a specific target molecule through a process known as biopanning.
Why Phage Display?
One of the key advantages of phage display is its scalability and flexibility. Researchers can construct vast libraries—ranging from 10⁹ to 10¹¹ variants—and efficiently screen them against diverse targets, including proteins, peptides, DNA, small molecules, and even living cells. The technique is highly selective, enabling the isolation of molecules with exquisite binding specificity and affinity.
Phage display is also cost-effective and relatively fast compared to traditional hybridoma-based approaches, especially for antibody generation. It allows for the humanization of antibodies, affinity maturation, and engineering of antibody fragments (such as scFv and Fab) for therapeutic or diagnostic applications.
Applications Across Industries
The applications of phage display span multiple domains:
Drug Discovery: Identification of peptide or protein ligands that bind to disease-relevant targets, such as enzymes, receptors, or tumor antigens.
Antibody Development: Generation of fully human or humanized monoclonal antibodies for therapeutic use.
Vaccine Design: Discovery of immunogenic epitopes and mimotopes to inform rational vaccine design.
Diagnostics: Development of highly specific molecular probes for imaging or biosensing applications.
Peptide Therapeutics: Selection of cell-penetrating peptides, tumor-targeting peptides, and receptor antagonists.
Our Phage Display Services
At KS-V Peptide, we offer a full suite of phage display services tailored to your research and development goals. From constructing high-diversity phage libraries to performing multi-round biopanning and downstream characterization, our team of experts delivers customized, efficient, and high-quality solutions.
Whether you are developing a novel biologic, exploring receptor-ligand interactions, or identifying peptide biomarkers, our services are designed to support innovation at every stage. We also offer optimization services such as affinity maturation and structure-function analysis to enhance the performance of your lead candidates.
Partner With Us
Our team combines deep expertise with advanced technologies to accelerate your peptide and antibody discovery pipeline. With a strong focus on quality and collaboration, we are committed to delivering results that meet your scientific and commercial objectives.
To learn more about our capabilities and stay updated with our latest innovations, please visit our LinkedIn page.
0コメント